You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 59 No. 4, April 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (34)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Alzheimer Disease
 •Neurogenetics
 •Genetic Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Association Between Apolipoprotein E Genotype and Alzheimer Disease in African American Subjects

Neill R. Graff-Radford, MD; Robert C. Green, MD, MPH; Rodney C. P. Go, PhD; Michael L. Hutton, PhD; Timi Edeki, MD, PhD; David Bachman, MD; Jennifer L. Adamson, PhD; Patrick Griffith, MD; Floyd B. Willis, MD; Mary Williams, EdD, PAC; Yvonne Hipps, PhD; Jonathan L. Haines, PhD; L. Adrienne Cupples, PhD; Lindsay A. Farrer, PhD

Arch Neurol. 2002;59:594-600.

Background  The association between Alzheimer disease (AD) and genotypes at the apolipoprotein E (APOE) locus has been confirmed in numerous populations worldwide, but appears to be inconsistent in African American subjects.

Objective  To investigate the association between APOE genotypes and AD in elderly African American subjects.

Design  Clinic-based, multicenter case-control study and a family study.

Participants  A total of 338 African American probands meeting criteria for probable or definite AD, 301 cognitively healthy, elderly unrelated control subjects (spouses and community volunteers), and 108 siblings of 88 AD probands.

Main Outcome Measures  Odds of AD according to APOE genotype.

Results  Compared with individuals with the APOE {epsilon}3/{epsilon}3, the odds of having AD were significantly increased among those with 1 or more copies of the {epsilon}4 allele; the odds ratio (OR) for the {epsilon}3/{epsilon}4 genotype was 2.6 (95% confidence interval [CI], 1.8-3.7), and the OR for the {epsilon}4/{epsilon}4 genotype was 10.5 (95% CI, 5.1-21.8). These risks decreased substantially after 68 years of age. The risk for AD was lower among individuals with the {epsilon}2/{epsilon}3 genotype (OR, 0.41; 95% CI, 0.22-0.79). The patterns of association were similar in men and women. These results obtained from comparisons of unrelated AD patients and controls were bolstered by results of analysis of family data that showed preferential transmission of the {epsilon}4 allele to demented siblings (P<<.001) and of the {epsilon}2 allele to nondemented siblings (P = .005).

Conclusions  The presence of 1 or 2 {epsilon}4 alleles is a determinant of AD risk in African American subjects. The age-related risk for decline associated with the {epsilon}4 allele and the apparent protective effect of the {epsilon}2 allele are similar to patterns observed in white subjects.


From the Departments of Neurology (Dr Graff-Radford), Neuroscience (Drs Hutton and Adamson), and Family Practice (Dr Willis), Mayo Clinic, Jacksonville, Fla; the Genetics Program, Department of Medicine, and the Department of Neurology, Boston University School of Medicine (Drs Green and Farrer), and the Department of Epidemiology and Biostatistics, Boston University School of Public Health (Drs Cupples and Farrer), Boston, Mass; the Department of Epidemiology, University of Alabama, Birmingham (Dr Go); the Departments of Pharmacology (Dr Edeki) and Medicine (Drs Edeki, Griffith, Williams, and Hipps), Morehouse School of Medicine, Atlanta, Ga; the Department of Neurology, Medical University of South Carolina, Charleston (Dr Bachman); and the Program in Human Genetics, Vanderbilt University School of Medicine, Nashville, Tenn (Dr Haines).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

RELATED ARTICLE

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2002;59(4):655-656.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Association of apolipoprotein e genotype and Alzheimer disease in african americans.
Murrell et al.
Arch Neurol 2006;63:431-434.
ABSTRACT | FULL TEXT  

Black-White Disparities in Functional Decline in Older Persons: The Role of Cognitive Function
Moody-Ayers et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2005;60:933-939.
ABSTRACT | FULL TEXT  

Variability of Familial Risk of Alzheimer Disease Across the Late Life Span
Silverman et al.
Arch Gen Psychiatry 2005;62:565-573.
ABSTRACT | FULL TEXT  

APOE genotype and cognitive decline in a middle-aged cohort
Blair et al.
Neurology 2005;64:268-276.
ABSTRACT | FULL TEXT  

Combined effects of APOE genotype, blood pressure, and antihypertensive drug use on incident AD
Qiu et al.
Neurology 2003;61:655-660.
ABSTRACT | FULL TEXT  

Genetic vulnerability following traumatic brain injury: the role of apolipoprotein E
Nathoo et al.
Mol. Pathol. 2003;56:132-136.
ABSTRACT | FULL TEXT  

Increased Risk of Late Posttraumatic Seizures Associated With Inheritance of APOE{epsilon}4 Allele
Diaz-Arrastia et al.
Arch Neurol 2003;60:818-822.
ABSTRACT | FULL TEXT  

Comparison of Alzheimer's disease risk factors in white and African American families
Bachman et al.
Neurology 2003;60:1372-1374.
ABSTRACT | FULL TEXT  

Apolipoprotein E, Alzheimer Disease, and African Americans
Mayeux
Arch Neurol 2003;60:161-163.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.